SMTL ID : 4li5.1 (1 other biounit)

EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] Prop-2-enamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.64 Å

Oligo State

monomer

Ligands

1 x 1WY: N-(3-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-4-methoxyphenyl)propanamide(Covalent)

1WY.1: 15 residues within 4Å: Chain A: L.26, G.27, F.31, V.34, A.51, T.98, Q.99, L.100, M.101, P.102, G.104, C.105, D.108, R.149, L.152 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.26, A:F.31, A:V.34, A:V.34 Hydrogen bonds: A:M.101, A:M.101, A:C.105

1 x NA: SODIUM ION(Non-functional Binders)

NA.2: 2 residues within 4Å: Chain A: E.275, K.278 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.275

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ward, R.A. et al., Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR). J.Med.Chem. (2013)

Release Date

2013-08-28

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence